Clinical Trials Logo

Clinical Trial Summary

A randomized, double blind, placebo-controlled, phase 2 clinical trial to investigate the efficacy and safety of 2 doses of NuSepin® intravenous infusion in COVID-19 pneumonia patients


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04565379
Study type Interventional
Source Shaperon
Contact
Status Completed
Phase Phase 2
Start date September 24, 2020
Completion date April 13, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04527224 - Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia Phase 1/Phase 2
Recruiting NCT03183570 - Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT Early Phase 1
Recruiting NCT04642040 - Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia N/A
Recruiting NCT04487951 - N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia
Active, not recruiting NCT04881214 - COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program N/A
Recruiting NCT04377750 - The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation Phase 4
Recruiting NCT04569227 - Prevention of COVID-19 Infection to Severe Pneumonia or ARDS Phase 2
Not yet recruiting NCT04344756 - Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort Phase 2
Completed NCT04535063 - Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia Phase 3
Not yet recruiting NCT04344782 - Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort Phase 2